Pricing Log in Create free account

CAMP4 Therapeutics Corporation (CAMP) vs Sol-Gel Technologies Ltd. (SLGL)

CAMP4 Therapeutics Corporation and Sol-Gel Technologies Ltd. are both Biotechnology companies. CAMP4 Therapeutics Corporation and Sol-Gel Technologies Ltd. are of similar size ($224.9M and $216.5M). Sol-Gel Technologies Ltd. has the higher net margin (−910.1% vs −2,543.7%) and the lower return on invested capital (−6,630.2% vs 0.00%). Across the 13 metrics below, Sol-Gel Technologies Ltd. leads on 7 and CAMP4 Therapeutics Corporation on 6.

Valuation

Metric CAMP SLGL Biotechnology median
P/E n/m n/m 8.50
P/S 43.56 117.08 9.71
P/B n/m 4.37 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 22.90 126.78 9.21
Earnings yield (73.19%) (8.78%) (33.15%)
Free cash flow yield (15.62%) (10.12%) (25.50%)

Profitability

Metric CAMP SLGL Biotechnology median
Gross margin 100.00% 100.00% 65.16%
Operating margin (1,254.22%) (986.96%) 0.00%
Net margin (2,543.74%) (910.14%) 0.00%
Free cash flow margin (680.36%) (1,185.18%) 0.00%
Return on equity (545.85%) (40.85%) (56.36%)
Return on assets (148.23%) (35.11%) (48.04%)
Return on invested capital 0.00% (6,630.24%) 0.00%

Growth

Metric CAMP SLGL Biotechnology median
Revenue growth (TTM) — (92.50%) 6.02%
EPS growth (last fiscal year) 76.00% 42.37% 30.26%
Revenue growth, 5-year CAGR — 17.19% 9.41%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric CAMP SLGL Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 4.70 10.37 4.72
Net debt to EBITDA 2.18 3.23 0.96

Dividend

Metric CAMP SLGL Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CAMP SLGL Biotechnology median
Market cap 216.50m 224.92m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack